Augustine Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-101,850
Closed -$5.54M 56
2015
Q3
$5.54M Buy
101,850
+30,350
+42% +$1.98M 4.23% 5
2015
Q2
$4.8M Sell
71,500
-5
-0% -$326 3.58% 7
2015
Q1
$4.55M Sell
71,505
-13,893
-16% -$839K 3.21% 10
2014
Q4
$5.59M Sell
85,398
-264
-0.3% -$16.6K 3.61% 10
2014
Q3
$4.95M Buy
85,662
+371
+0.4% +$20.6K 3.12% 10
2014
Q2
$4.81M Sell
85,291
-563
-0.7% -$29.5K 3.07% 10
2014
Q1
$4.41M Buy
85,854
+73,740
+609% +$3.73M 3.07% 15
2013
Q4
$640K Sell
12,114
-8,550
-41% -$420K 0.38% 46
2013
Q3
$924K Buy
20,664
+145
+0.7% +$6.43K 0.64% 41
2013
Q2
$848K Buy
+20,519
New +$897K 0.58% 45

Other funds holding ABBV

Augustine Asset Management's ABBV Position: Q4 2015 in Review

Augustine Asset Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 101,850 shares — an estimated $5.54M sold.

Augustine Asset Management first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $5.59M in Q4 2014. 1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Augustine Asset Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Augustine Asset Management sold 101,850 AbbVie shares in Q4 2015, an estimated $5.54M.
  • Augustine Asset Management first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
  • Augustine Asset Management's AbbVie position peaked at $5.59M in Q4 2014.
  • 1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Augustine Asset Management's 13F filing for Q4 2015, filed 19 Jan 2016.